Belgium vs Singapore: Coverage of the human papillomavirus vaccine
Belgium
72
in 2025
Singapore
71
in 2025
Belgium rank
36th
Singapore rank
39th
Coverage of the human papillomavirus vaccine over time
- Belgium
- Singapore
How they compare
Belgium currently reports 72 against 71 in Singapore, a difference of 1.
The two have swapped places 2 times across 13 shared years of data; in 2013 it was Belgium ahead.
Belgium ranks 36th and Singapore ranks 39th of 85 countries.
Belgium has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belgium | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 64.71 | 0.5714 | 64.14 | Belgium |
| 2020s | 70.5 | 65.5 | 5 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Belgium or Singapore?
- Belgium, at 72 against 71 in Singapore as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Belgium and Singapore?
- 1, with Belgium ahead.
- How many years of comparable data are there for Belgium and Singapore?
- 13 years are reported by both, from 2013 to 2025.
- How do Belgium and Singapore rank globally for coverage of the human papillomavirus vaccine?
- Belgium ranks 36th and Singapore ranks 39th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.